(“C4XD”, “C4X Discovery” or the “Company”)
Clive Dix appointed to the UK Vaccine Taskforce
Government’s taskforce to lead UK efforts to deliver a COVID-19 vaccine
5 June 2020 – C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, is pleased to confirm that Clive Dix, Chief Executive Officer of C4XD has been appointed a member and Deputy Chair of the Steering Board of the UK Vaccine Taskforce, the group set up by the Government’s Chief Scientific Adviser, Deputy Chief Medical Officer, Business Secretary and Health Secretary to lead UK efforts to find and manufacture a COVID-19 vaccine.
Clive remains committed to delivering C4XD’s strategy and this appointment will not impact his day-to-day role as CEO.
Eva-Lotta Allan, Chairman of C4XD, commented:
“We are very proud that Clive has been appointed to this important and prestigious taskforce. COVID-19 has had such a devastating impact not only in the UK, but across the world. The development of a vaccine is vital to saving lives and enabling everyone to get back to normality. The taskforce has been assembled to bring together the brightest minds in the scientific industry to deliver a COVID-19 vaccine that will be effective and accessible. Clive’s rich and diverse experience, both as a scientist and from managing pharmaceutical companies, means he understands what is required to bring a product like this to market. This will be invaluable to the taskforce as it works quickly to find a solution to the COVID-19 pandemic.”